Cargando…

Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines

BACKGROUND: Authors of clinical practice guidelines (CPGs) disclose financial conflicts of interest (FCOIs) to promote transparency ethics. Typically, they do so on standard declaration forms containing generic open-ended questions on FCOIs. Yet, the literature is scant on the format and effect of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yidan, Jones, Derek J., Sharara, Nour, Kaltenbach, Tonya, Laine, Loren, McQuaid, Kenneth, Soetikno, Roy, Subramanian, Venkataraman, Barkun, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571907/
https://www.ncbi.nlm.nih.gov/pubmed/28841650
http://dx.doi.org/10.1371/journal.pone.0182856
_version_ 1783259427166486528
author Lu, Yidan
Jones, Derek J.
Sharara, Nour
Kaltenbach, Tonya
Laine, Loren
McQuaid, Kenneth
Soetikno, Roy
Subramanian, Venkataraman
Barkun, Alan
author_facet Lu, Yidan
Jones, Derek J.
Sharara, Nour
Kaltenbach, Tonya
Laine, Loren
McQuaid, Kenneth
Soetikno, Roy
Subramanian, Venkataraman
Barkun, Alan
author_sort Lu, Yidan
collection PubMed
description BACKGROUND: Authors of clinical practice guidelines (CPGs) disclose financial conflicts of interest (FCOIs) to promote transparency ethics. Typically, they do so on standard declaration forms containing generic open-ended questions on FCOIs. Yet, the literature is scant on the format and effect of alternative disclosure forms. Does supplementing a standard form with subsequent detailed disclosure forms tailored to the context of the CPG improve the yield or accuracy of FCOIs declarations? METHODS: For an international CPG in gastroenterology on the endoscopic surveillance for colorectal neoplasia in inflammatory bowel disease, we compared the use of a standard FCOIs disclosure form with a contextual FCOIs disclosure form that detailed commercial relations related to the CPG topic. This included manufacturers of endoscopes, endoscopy equipment and accessories. Participants completed the generic form early, and the supplementary contextual form six months later. We then compared the FCOI disclosures obtained. FINDINGS: 26 participants provided FCOIs disclosures using both disclosure forms. We found discrepancies regarding (1) the disclosure of FCOIs (presence/absence), and (2) the listing of financial entities. While the number of participants who disclosed a FCOI remained the same (30.8%) using the two forms, disclosures were not from the same individuals: two additional participants disclosed a FCOI, whereas two participants withdrew previous disclosures. Among those who reported a FCOI in either form, we noted inconsistencies in disclosures for 70% of the participants. This included changes in FCOIs disclosure status or modifications of "their commercial relations". DISCUSSION: Accurate reporting of FCOIs advances the transparency and ethical integrity of CPGs. Our experience suggests that a contextual FCOIs disclosure form tailored to content of the CPG with narrow, detailed questions provides supplementary, more complete FCOIs declarations than generic forms alone. The finding raises challenges on how forms are best written and formatted, optimally timed, and more effectively processed with sensitivity to professional behaviour, so as to heighten transparency.
format Online
Article
Text
id pubmed-5571907
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55719072017-09-09 Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines Lu, Yidan Jones, Derek J. Sharara, Nour Kaltenbach, Tonya Laine, Loren McQuaid, Kenneth Soetikno, Roy Subramanian, Venkataraman Barkun, Alan PLoS One Research Article BACKGROUND: Authors of clinical practice guidelines (CPGs) disclose financial conflicts of interest (FCOIs) to promote transparency ethics. Typically, they do so on standard declaration forms containing generic open-ended questions on FCOIs. Yet, the literature is scant on the format and effect of alternative disclosure forms. Does supplementing a standard form with subsequent detailed disclosure forms tailored to the context of the CPG improve the yield or accuracy of FCOIs declarations? METHODS: For an international CPG in gastroenterology on the endoscopic surveillance for colorectal neoplasia in inflammatory bowel disease, we compared the use of a standard FCOIs disclosure form with a contextual FCOIs disclosure form that detailed commercial relations related to the CPG topic. This included manufacturers of endoscopes, endoscopy equipment and accessories. Participants completed the generic form early, and the supplementary contextual form six months later. We then compared the FCOI disclosures obtained. FINDINGS: 26 participants provided FCOIs disclosures using both disclosure forms. We found discrepancies regarding (1) the disclosure of FCOIs (presence/absence), and (2) the listing of financial entities. While the number of participants who disclosed a FCOI remained the same (30.8%) using the two forms, disclosures were not from the same individuals: two additional participants disclosed a FCOI, whereas two participants withdrew previous disclosures. Among those who reported a FCOI in either form, we noted inconsistencies in disclosures for 70% of the participants. This included changes in FCOIs disclosure status or modifications of "their commercial relations". DISCUSSION: Accurate reporting of FCOIs advances the transparency and ethical integrity of CPGs. Our experience suggests that a contextual FCOIs disclosure form tailored to content of the CPG with narrow, detailed questions provides supplementary, more complete FCOIs declarations than generic forms alone. The finding raises challenges on how forms are best written and formatted, optimally timed, and more effectively processed with sensitivity to professional behaviour, so as to heighten transparency. Public Library of Science 2017-08-25 /pmc/articles/PMC5571907/ /pubmed/28841650 http://dx.doi.org/10.1371/journal.pone.0182856 Text en © 2017 Lu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lu, Yidan
Jones, Derek J.
Sharara, Nour
Kaltenbach, Tonya
Laine, Loren
McQuaid, Kenneth
Soetikno, Roy
Subramanian, Venkataraman
Barkun, Alan
Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
title Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
title_full Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
title_fullStr Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
title_full_unstemmed Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
title_short Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
title_sort transparency ethics in practice: revisiting financial conflicts of interest disclosure forms in clinical practice guidelines
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571907/
https://www.ncbi.nlm.nih.gov/pubmed/28841650
http://dx.doi.org/10.1371/journal.pone.0182856
work_keys_str_mv AT luyidan transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT jonesderekj transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT shararanour transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT kaltenbachtonya transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT laineloren transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT mcquaidkenneth transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT soetiknoroy transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT subramanianvenkataraman transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines
AT barkunalan transparencyethicsinpracticerevisitingfinancialconflictsofinterestdisclosureformsinclinicalpracticeguidelines